Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ChemoCentryx, a company focusing on chemoattractant receptors, reviews company outlook

Jan. 28, 2015

Phase I data for ABT-700 in GEC patients

Jan. 27, 2015

Five Prime Therapeutics reviews product development

Jan. 27, 2015

ZIOPHARM Oncology presents ongoing projects

Jan. 26, 2015

PF-04136309 and FOLFIRINOX shows no additional toxicity in pancreatic adenocarcinoma

Jan. 26, 2015

Combination of pimasertib and gemcitabine fails to improve PFS

Jan. 26, 2015

Cabozantinib S-malate shows limited activity in advanced CCA patients

Jan. 26, 2015

Safety and toxicity results presented for pralatrexate plus oxaliplatin combination treatment

Jan. 26, 2015

Final results of phase I/II study of ISIS-183750 plus irinotecan

Jan. 23, 2015

Pilot study investigates imaging markers to guide PBT-2 development

Jan. 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...